Midwest Professional Planners Ltd (MPPL)’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,106
Closed -$445K 159
2024
Q3
$445K Buy
11,106
+966
+10% +$44.9K 0.14% 133
2024
Q2
$483K Buy
10,140
+424
+4% +$17.4K 0.16% 111
2024
Q1
$421K Buy
9,716
+1,197
+14% +$57.1K 0.15% 115
2023
Q4
$431K Buy
8,519
+694
+9% +$33.2K 0.17% 95
2023
Q3
$355K Buy
7,825
+1,232
+19% +$50.8K 0.16% 97
2023
Q2
$271K Buy
+6,593
New +$253K 0.12% 110

Other funds holding IONS

Midwest Professional Planners Ltd (MPPL)'s IONS Position: Q4 2024 in Review

Midwest Professional Planners Ltd (MPPL) sold out of Ionis Pharmaceuticals (IONS) in Q4 2024, closing a stake of 11,106 shares — an estimated $445K sold.

Midwest Professional Planners Ltd (MPPL) first reported a position in IONS in Q2 2023 and held it in 6 quarters. The position peaked at $483K in Q2 2024. 354 funds tracked by Wall St. Rank hold IONS as of Q4 2024.

  • Midwest Professional Planners Ltd (MPPL) reported no remaining Ionis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Midwest Professional Planners Ltd (MPPL) sold 11,106 Ionis Pharmaceuticals shares in Q4 2024, an estimated $445K.
  • Midwest Professional Planners Ltd (MPPL) first reported a position in Ionis Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • Midwest Professional Planners Ltd (MPPL)'s Ionis Pharmaceuticals position peaked at $483K in Q2 2024.
  • 354 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2024.

Based on Midwest Professional Planners Ltd (MPPL)'s 13F filing for Q4 2024, filed 10 Feb 2025.